ArticleScience advances2024

An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil.

Irina Gaisina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.